Pesquisar
MeiraGTx Holdings PLC
MGTXAdicionar à lista de desejos
13.920USD
+1.120+8.75%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
1.13BValor de mercado
PerdaP/L TTM
Mais detalhes de MeiraGTx Holdings PLC Empresa
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.
Informações de MeiraGTx Holdings PLC
Código da empresaMGTX
Nome da EmpresaMeiraGTx Holdings PLC
Data de listagemJun 08, 2018
CEOForbes (Alexandria)
Número de funcionários381
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 08
Endereço655 Third Avenue
CidadeNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10017
Telefone16468607985
Sitehttps://meiragtx.com/
Código da empresaMGTX
Data de listagemJun 08, 2018
CEOForbes (Alexandria)
Executivos da empresa MeiraGTx Holdings PLC
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Alexandria Forbes, Ph.D.
Dr. Alexandria Forbes, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.39M
-4.47%
Mr. Richard Giroux
Mr. Richard Giroux
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
1.05M
-0.66%
Dr. Stuart Naylor, Ph.D.
Dr. Stuart Naylor, Ph.D.
Chief Development Officer
Chief Development Officer
668.50K
-4.14%
Dr. Keith R. Harris, Ph.D.
Dr. Keith R. Harris, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
200.00K
+37.50%
Mr. Robert K. Zeldin, M.D.
Mr. Robert K. Zeldin, M.D.
Chief Medical Officer
Chief Medical Officer
171.80K
-0.00%
Mr. Thomas E. Shenk, Ph.D.
Mr. Thomas E. Shenk, Ph.D.
Independent Director
Independent Director
157.48K
--
Mr. Robert J. Wollin, J.D.
Mr. Robert J. Wollin, J.D.
General Counsel, Secretary
General Counsel, Secretary
57.38K
+9.24%
Ms. Ellen Hukkelhoven, Ph.D.
Ms. Ellen Hukkelhoven, Ph.D.
Independent Director
Independent Director
--
--
Mr. Neil F. J. (Lord) Mendoza
Mr. Neil F. J. (Lord) Mendoza
Independent Director
Independent Director
--
--
Ms. Nicole Seligman
Ms. Nicole Seligman
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Alexandria Forbes, Ph.D.
Dr. Alexandria Forbes, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.39M
-4.47%
Mr. Richard Giroux
Mr. Richard Giroux
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
1.05M
-0.66%
Dr. Stuart Naylor, Ph.D.
Dr. Stuart Naylor, Ph.D.
Chief Development Officer
Chief Development Officer
668.50K
-4.14%
Dr. Keith R. Harris, Ph.D.
Dr. Keith R. Harris, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
200.00K
+37.50%
Mr. Robert K. Zeldin, M.D.
Mr. Robert K. Zeldin, M.D.
Chief Medical Officer
Chief Medical Officer
171.80K
-0.00%
Mr. Thomas E. Shenk, Ph.D.
Mr. Thomas E. Shenk, Ph.D.
Independent Director
Independent Director
157.48K
--
Perguntas frequentes
Quem são os cinco principais acionistas de MeiraGTx Holdings PLC?
Os cinco principais acionistas de MeiraGTx Holdings PLC são: Dr. Alexandria Forbes, Ph.D.
Quantas instituições possuem ações da MeiraGTx Holdings PLC (MGTX)?
Em 2026Q1, 249 instituições possuíam ações da MeiraGTx Holdings PLC, com valor de mercado aproximado de 53.71M, representando 59.59% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1739317.00.